Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Brooks BR, Juhasz-Poscine K, Waclawik A, Sanjak M, Belden D, Roelke K, Parnell J, Weasler C. Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists. ACTA ACUST UNITED AC 2009. [DOI: 10.1080/14660820050515700] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]

For:	Brooks BR, Juhasz-Poscine K, Waclawik A, Sanjak M, Belden D, Roelke K, Parnell J, Weasler C. Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists. ACTA ACUST UNITED AC 2009. [DOI: 10.1080/14660820050515700] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]

Number	Cited by Other Article(s)
1	THEME 4 RESPIRATORY AND NUTRITIONAL MANAGEMENT. Amyotroph Lateral Scler Frontotemporal Degener 2014;15 Suppl 1:93-106. [DOI: 10.3109/21678421.2014.960177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
2	Brooks BR, Sanjak M. Disease-modifying drug therapies. ACTA ACUST UNITED AC 2005;5 Suppl 1:68-75. [PMID: 15512878 DOI: 10.1080/17434470410019898] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Abstract Collapse Key Words Collapse MESH Headings Adult Age Factors Age of Onset Amyotrophic Lateral Sclerosis/complications Amyotrophic Lateral Sclerosis/drug therapy Amyotrophic Lateral Sclerosis/epidemiology Amyotrophic Lateral Sclerosis/mortality Antirheumatic Agents/therapeutic use Bulbar Palsy, Progressive/drug therapy Bulbar Palsy, Progressive/etiology Cohort Studies Female Humans Longitudinal Studies Male Middle Aged Neuroprotective Agents/therapeutic use Retrospective Studies Riluzole/therapeutic use Survival Rate Time Factors Treatment Outcome Collapse Grants Collapse Affiliation(s) Collapse